AndreyPopov / iStockphoto.com
18 May 2017Americas
ResMed seeks to dismiss ITC investigation, but plans to refile
Medical device company ResMed has filed a motion to dismiss its International Trade Commission (ITC) complaint against New Zealand-based Fisher & Paykel.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
12 September 2018 Medical device maker Fisher & Paykel Healthcare filed a complaint with the US International Trade Commission yesterday against rival ResMed.
Americas
2 October 2018 The US International Trade Commission yesterday announced that it will launch a patent infringement investigation into medical device maker Fisher & Paykel Healthcare, based in New Zealand.
Editor's picks
Editor's picks
Americas
2 October 2018 The US International Trade Commission yesterday announced that it will launch a patent infringement investigation into medical device maker Fisher & Paykel Healthcare, based in New Zealand.
Americas
12 September 2018 Medical device maker Fisher & Paykel Healthcare filed a complaint with the US International Trade Commission yesterday against rival ResMed.
Americas
2 October 2018 The US International Trade Commission yesterday announced that it will launch a patent infringement investigation into medical device maker Fisher & Paykel Healthcare, based in New Zealand.
Americas
12 September 2018 Medical device maker Fisher & Paykel Healthcare filed a complaint with the US International Trade Commission yesterday against rival ResMed.